Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder

Bipolar Disorders

Volumn 10, Issue 1, 2008, Pages 105-110

  Xu, Chun ^a   Li, Peter P ^a,b,c   Kennedy, James L ^a,b,d   Green, Marty ^a   Hughes, Bronwen ^a   Cooke, Robert G ^a,b   Parikh, Sagar V ^a,b   Warsh, Jerry J ^a,b,c,d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b Department of Psychiatry ^*  (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bipolar disorder; Calcium homeostasis; Haplotype analysis; NDUFV2; Single nucleotide polymorphisms; SNP

Indexed keywords

CALCIUM; MESSENGER RNA; PROTEIN NDUFV 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; B LYMPHOBLAST; BIPOLAR DISORDER; CALCIUM CELL LEVEL; CHILD; CONTROLLED STUDY; EUROPEAN AMERICAN; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; PATHOGENESIS; POPULATION DISTRIBUTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; NADH DEHYDROGENASE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 38049110230     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2008.00535.x     Document Type: Article

References (23)

1. Bianchi K, Rimessi A, Prandini A et al. Calcium and mitochondria: mechanisms and functions of a troubled relationship. Biochim Biophys Acta 2004; 1742: 119-131.
2. Kato T. The other, forgotten genome: Mitochondrial DNA and mental disorders. Mol Psychiatry 2001; 6: 625-633.
3. Warsh JJ, Andreopoulos S, Li PP. Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: Current status. Clin Neurosci Res 2004; 4: 201-213.
4. Washizuka S, Kakiuchi C, Mori K et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet 2003; 120: 72-78.
5. Washizuka S, Kametani M, Sasaki T et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 301-304.
6. Brini M, Pinton P, King MP et al. A calcium-signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nature Med 1999; 5: 951-954.
7. Smeitink J, van den HL, DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2001; 2: 342-352.
8. Sklar P. Linkage analysis in psychiatric disorders: The emerging picture. Annu Rev Genomics Hum Genet 2002; 3: 371-413.
9. Baron M. Manic-depression genes and the new millennium: Poised for discovery. Mol Psychiatry 2002; 7: 342-358.
10. Washizuka S, Iwamoto K, Kazuno AA et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees. Biol Psychiatry 2004; 56: 483-489.
11. Nakatani N, Hattori E, Ohnishi T et al. Genome-wide expression analysis detects 8 genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet 2006; 15: 1949-1962.
12. Karry R, Klein E, Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: A postmortem study. Biol Psychiatry 2004; 55: 676-684.
13. First MB, Spitzer RL, Gibbon M, Williams JB ed. Structured clinical interview for DSM-IV axis I disorders, patient edition (SCID-I/P, version 2.0, 8/98 revision). Biometric Research Department, New York State Psychiatric Institute, New York, 1998.
14. Emamghoreishi M, Schlichter L, Li PP et al. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry 1997; 154: 976-982.
15. Xu C, Macciardi F, Li PP et al. Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 36-43.
16. Barrett JC, Fry B, Maller J et al. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
17. Dudbridge F. UNPHASED user guide. Technical Report 2006/5, MRC Biostatistics Unit, Cambridge, UK. UNPHASED, 2005. http://www.mrc-bsu.cam.uk/personal/frank/software/unphased (accessed February 26, 2007).
18. Applied Biosystems Inc. SNP database of assay-on-demand. Foster City, CA: Applied Biosystems Inc., 2005. http://www.allsnps.com.
19. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
20. MacQueen GM, Hajek T, Alda M. The phenotypes of bipolar disorder: relevance for genetic investigations. Mol Psychiatry 2005; 10: 811-826.
21. Kakiuchi C, Iwamoto K, Ishiwata M et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 2003; 35: 171-175.
22. Hayes MG, Del Bosque-Plata L, Tsuchiya T et al. Patterns of linkage disequilibrium in the type 2 diabetes gene calpain-10. Diabetes 2005; 54: 3573-3576.
23. Naydenov AV, MacDonald ML, Ongur D, et al. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry 2007; 64: 555-564.